Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Meiji Seika Pharma Co Ltd patents

Recent patent applications related to Meiji Seika Pharma Co Ltd. Meiji Seika Pharma Co Ltd is listed as an Agent/Assignee. Note: Meiji Seika Pharma Co Ltd may have other listings under different names/spellings. We're not affiliated with Meiji Seika Pharma Co Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Meiji Seika Pharma Co Ltd-related inventors

Nitrogen-containing heterocyclic derivative having 2-imino group and pest control agent including the same

[in the formula, Ar represents a phenyl group which may be substituted, a 5- to 6-membered heterocycle which may be substituted, or a 4- to 10-membered heterocycloalkyl group, A represents a heterocycle having a 5- to 10-membered unsaturated bond including one or more nitrogen atoms, and has an imino group... Meiji Seika Pharma Co Ltd

N-[1-((6-chloropyridin-3-yl)methyl)pyridin-2(1h)-ylidene]-2,2,2- trifluoroacetamide for control of agricultural/horticultural pests

wherein Ar′, R1, R4e and Y are as defined herein and a method of controlling pests using the compound.... Meiji Seika Pharma Co Ltd

Production process of crystals of diazabicyclooctane derivative and stable lyophilized preparation

by crystallizing the compound from an aqueous solution containing the compound and an inorganic salt, such as sodium chloride. Such crystals can be subjected to lyophilization to provide a lyophilized composition having a desirable storage stability... Meiji Seika Pharma Co Ltd

Process for producing diazabicyclooctane derivative

wherein OBn is benzyloxy and R2 is hydrogen, ClCO— or Cl3COCO—.... Meiji Seika Pharma Co Ltd

Local administration-type pharmaceutical for improving dysphagia

A dysphagia improving composition characterized in that a substance having an inhibitory action on an angiotensin converting enzyme, which is a degrading enzyme of substance P, is administered locally in a dosage not influencing blood pressure, and a pharmaceutical for improving dysphagia containing the composition.... Meiji Seika Pharma Co Ltd

Plant growth-promoting agent and plant growth-promoting method

A novel plant growth-promoting agent and a plant growth-promoting method using the same are provided. The plant growth-promoting agent contains a lactic acid bacterium having a plant growth-promoting action. Also, in the plant growth-promoting method, a seed, a plant body and/or a soil is treated with a lactic acid bacterium... Meiji Seika Pharma Co Ltd

Crystalline anti-trichophyton agents and preparation process thereof

A crystal form of 2-(3,5-dimethyl-1H-pyrazol-1-yl)-5-methylphenol which is stable and has high purity for preservation, industrial manufacturing, and circulation, and process for providing the same by using a boron compound.... Meiji Seika Pharma Co Ltd

Beta-lactamase inhibitor and process for preparing the same

wherein in the formula (IV-c), OBn represents benzyloxy, and (b) carrying out an intramolecular urea formation reaction.... Meiji Seika Pharma Co Ltd

Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same

An objective of the present invention is to provide novel cyclic depsipeptide derivatives and harmful organism control agents including the same as each other. Specifically, the present invention provides compounds represented by formula (1) or stereoisomers thereof, harmful organism control agents containing them, and a process for producing them.... Meiji Seika Pharma Co Ltd

Stable aqueous adalimumab formulation

The present invention provides a stable aqueous adalimumab formulation by incorporating a histidine buffer solution and a phosphate buffer solution in combination. The incorporation of the histidine buffer solution and the phosphate buffer solution makes it possible to improve the stability of adalimumab.... Meiji Seika Pharma Co Ltd

Mutant xylanase, manufacturing method and use therefor, and manufacturing saccharified lignocellulose

What is aimed at is provision of an inexpensive and efficient saccharification method for lignocellulose using a thermostable xylanase and provision of a mutant xylanase that has a substitute amino acid residue, and that exhibits stable activity even under severe conditions in which enzymes easily inactivate, and that provides an... Meiji Seika Pharma Co Ltd

Method for producing 2-acyliminopyridine derivative

further alkylating a nitrogen atom at position 1 of the compound represented by formula (B), as follows... Meiji Seika Pharma Co Ltd

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Meiji Seika Pharma Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Meiji Seika Pharma Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by